AP
Therapeutic Areas
EMD Serono Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Xevinapant | Locally Advanced Head and Neck Cancer | Phase 3 |
| Evobrutinib | Multiple Sclerosis | Phase 3 |
| BAVENCIO (avelumab) | Various Solid Tumors | Approved |
| GONAL-f (follitropin alfa) | Infertility | Approved |
| REBIF (interferon beta-1a) | Multiple Sclerosis | Approved |